Becoming independent, rebranding, fundraising, investments, reinvestments, disposals and internal structuring are all major stages in a management company’s life, and Andera Partners’ staff have successfully completed all of them in barely 12 months. This scale-up confirms Andera Partners’ benchmark status for investment in unlisted SMEs in France and Europe as well as in the global biotechnologies and medical technologies financing market.

A new era

On 16 March 2018, EdRIP’s employees and shareholders completed the acquisition of the 51% of the management company’s share capital held by the Edmond de Rothschild group. The company has thus become independent at a time when private equity is evolving into a major asset class, its aim being to consolidate its four investment activities and establish itself as a key player both in France and internationally.

This scaling up and shifting of position is also illustrated by its new name, Andera Partners, and its new visual identity. The name begins with a strong And, symbolising the partnership created with investors, business owners and staff, and ends with Era, representing renewal.

While the new entity maintains its partnership structure, introduced in 2016, it has renewed its governance through the election in July 2018 of its Board of Partners’ ten new members and the appointment for two years of a new two-person management team. One of the board’s tasks is to develop and grow Andera Partners’ business, with a target of €5 billion in assets under management by 2025, illustrating the company’s intention to position itself as a player in the consolidation of the European private equity market through external growth and staff recruitment. As well as strengthening its internal structure, as from 2016, by professionalising and internalising its compliance and internal control, development, communication and HR functions, it has appointed a Finance Director through an in-house promotion, as well as an Operations Director, and set up a company-wide ESG unit.

Wholesale renewal of funds

In 2018, Andera Partners finished revamping its funds, which began in 2016 for its €170 million Cabestan Capital 2 small-cap business and in 2017 for its €315 million ActoMezz 3 sponsorless mezzanine business, and has resulted in a doubling in size from that of the previous vehicles.

In February 2018, BioDiscovery announced the completion of its fifth generation fundraising at €345 million ($420 million). Exceeding its initial target of €250 million, it has thus become one of Europe’s largest venture capital funds dedicated to life sciences and medical technologies.

In November 2018, the mid-cap franchise Winch Capital completed its fourth fund’s fundraising at €445 million, exceeding its initial target of €350 million and – by 50% – that of its predecessor Winch Capital 3 (€300 million). Andera Partners is thus developing one of the largest investment vehicles in Europe’s mid-cap and SME growth capital market.

The success of these two rounds, the last of which was completed without the support of the management company’s historical shareholder, reflects the confidence of its historical investor base and the attractiveness of its positioning for new investors, including several foreign investors.

 

 

Sustained activity

In 2018, Andera Partners’ various teams deployed nearly €250 million in capital and mezzanine financing, supporting 17 new managers in their companies’ growth projects and reinvesting in 14 existing portfolio companies.

With 13 disposals throughout the year, the teams generated more than €350 million in sale proceeds. Notable exits included Exclusive Group and SFAM (Winch Capital); French mid-caps transformed in a few years into international unicorns, valued at more than €1 billion; A2iA (Cabestan Capital) via its sale to the US listed group Mitek, which created a globally unrivalled centre of excellence in artificial intelligence and machine learning; and ADF (ActoMezz), an industrial engineering and maintenance services major.

The BioDiscovery franchise distinguished itself notably through two Nasdaq IPOs in October 2018: LogicBio Therapeutics (gene therapy for paediatric diseases) and Axonics Modulation Technologies (neurostimulation system for urinary incontinence).

A high-performance, influential platform that meets economic challenges

Andera Partners now has a 62-strong team, including 45 investors, based in France and Italy and managing more than €2.3 billion. It supports the managers of 99 French, European and US companies with total 2018 sales of nearly €5.8 billion and EBITDA of around €630 million. These companies span almost all economic sectors and employ more than 39,000 people.

In addition to its impact on the real economy, Andera Partners is also very active in therapeutic innovation. Its BioDiscovery franchise has enabled the market roll-out of 19 therapeutic products and medical technologies, and currently has several dozen products awaiting validation in areas such as oncology and orphan or cardiovascular diseases, for various therapeutic periods.

In addition to the development and growth of the management company and its investments, Andera Partners is also investing in its societal role with the aim of making finance socially useful. Among the recent initiatives it has announced and introduced are several in-house measures to reduce its carbon footprint and a partnership with H-UP Entrepreneurs, an association that supports disabled business owners in their business start-up and growth projects, due for implementation in early 2019.

Share on :

More news

AVERTISSEMENT - CAUTION

TEMPS DE LECTURE : 2 MINUTES

READING TIME: 2 MINUTES


TENTATIVE DE FRAUDE : À LIRE ATTENTIVEMENT
ATTEMPTED FRAUD: READ IT CAREFULLY (English below)

ANDERA PARTNERS attire votre attention sur les tentatives de fraudes avec usurpation d’identité qui sévissent actuellement. Les techniques de phishing (ou hameçonnage) évoluent en permanence et sont de plus en plus sophistiquées.

Ces pratiques frauduleuses qui touchent ANDERA PARTNERS, invitent les particuliers à investir dans des comptes à terme et autres produits d’épargne fictifs sous l’identité d’ ANDERA PARTNERS (Andera Co-Invest notamment), et celles de ses collaborateurs et membres des organes de direction, via une adresse fictive et des appels téléphoniques.

Nous vous invitons à la plus grande vigilance si vous receviez ce type de sollicitations. ANDERA PARTNERS ne propose pas de compte à terme et n’a recours à aucun démarchage auprès du public, ni par téléphone ni par courriel.

Les fraudeurs ne manquent pas d'imagination pour piéger leurs victimes. Leurs actions visent à récupérer à leur insu et de manière indue des données financières, en incitant leurs victimes à réaliser des transactions dématérialisées.
En cas de doute, pour vous protéger et protéger ANDERA PARTNERS, nous vous invitons à :

*   Vous méfier des demandes inattendues, même si elles semblent provenir de dirigeants ou membre d’organes de direction d’ANDERA PARTNERS ;

*   Vérifier l’adresse de l’expéditeur. Les adresses électroniques des collaborateurs d’ANDERA PARTNERS utilisent un seul et même format : initialeduprénom.nom@anderapartners.com. Les adresses globales sont ainsi libellées : nomduservice@anderapartners.com ;

*   Ne jamais cliquer sur un lien vous demandant de partager des informations sensibles et ne jamais répondre à des demandes financières en ligne ;

*   Signaler tout message suspect qui vous demande une action immédiate.

La priorité d'ANDERA PARTNERS est de protéger ses clients et ses activités contre la fraude.
Si vous êtes victime d'une tentative d’escroquerie, veuillez contacter les relations investisseurs à l’adresse suivante : ri@anderapartners.com

Liens utiles :

LISTE NOIRE DES SOCIÉTÉS FRAUDULEUSES ÉTABLIE PAR L’AMF (AUTORITÉ DES MARCHÉS FINANCIERS) : https://www.amf-france.org/fr/espace-epargnants/proteger-son-epargne/listes-noires-et-mises-en-garde

VICTIME D'UNE ARNAQUE : COMMENT DÉPOSER UNE PLAINTE ? | AMF (AMF-FRANCE.ORG) : https://www.amf-france.org/fr/espace-epargnants/savoir-bien-investir/conseils-pratiques/en-cas-de-problemes/victime-dune-arnaque

_____________________________________________________________

ANDERA PARTNERS would like to draw your attention to fraud attempts involving identity theft that are currently rife. Phishing techniques are constantly evolving and becoming increasingly sophisticated.

These fraudulent practices, which affect ANDERA PARTNERS, invite individuals to invest in term accounts and other fictitious savings products under the identity of ANDERA PARTNERS (Andera Co-Invest in particular), and those of its employees and members of the management company, via a fictitious address and telephone calls.

Please be extremely vigilant if you receive this type of solicitation. ANDERA PARTNERS does not offer term accounts and does not canvass the public by telephone or e-mail.

Fraudsters do not lack imagination to trap their victims. Their actions are aimed at unknowingly and improperly recovering financial data, by encouraging their victims to carry out dematerialised transactions.
If in doubt, to protect yourself and ANDERA PARTNERS, we invite you to :

* Be wary of unexpected requests, even if they appear to come from ANDERA PARTNERS managers or members of management bodies;

* Check the sender's address. The e-mail addresses of ANDERA PARTNERS employees use a single format: initialeduprénom.nom@anderapartners.com. Global addresses are written as follows: nomduservice@anderapartners.com ;

* Never click on a link asking you to share confidential information and never respond to online financial requests;

* Report any suspicious message that asks you to take immediate action.

ANDERA PARTNERS' priority is to protect its customers and its business against fraud.
If you are the victim of a fraud attempt, please contact Investor Relations at the following address: ri@anderapartners.com

This will close in 0 seconds